2 weeks ago

Freeport-McMoRan (FCX) Stock Plunges 10% After Slashing Production Forecasts

Freeport-McMoRan (FCX) stock plunged 10% despite strong Q1 results after the company reduced 2026 copper and gold forecasts due to...

2 weeks ago

Applied Digital (APLD) Stock Rallies 12% on Massive $7.5B Hyperscaler Agreement

Applied Digital (APLD) stock rallied 12% after announcing a $7.5B hyperscaler lease deal at Delta Forge 1, pushing total contracte...

2 weeks ago

DeFi Just Lost $15 Billion in Three Days. Something Deeper Than a Hack Is Behind...

DeFi is having one of its most difficult weeks in recent memory. What started as a single exploit on April 19 has since cascaded i...

2 weeks ago

OKX accelerates US push with BitGo off-exchange settlement

OKX integrates BitGo off-exchange settlement for US institutions, reducing pre-funding requirements and marking a key step in its...

2 weeks ago

The $145 billion math: Why bitcoin’s quantum threat is manageable, not existenti...

Quantum fears focus on vulnerable early wallets, but market data suggests even a worst case sell-off would be large, not catastrop...

2 weeks ago

Leidos (LDOS) Secures $617M Army Contract for Air Defense Systems

Leidos (LDOS) secures $617M U.S. Army contract for air defense launchers, bringing IFPC Inc 2 program total to nearly $1.2B with 1...

2 weeks ago

Ripple-linked XRP slips amid bitcoin profit-taking, ETF delay

Token falls 2.5% after rejection near $1.44 as leveraged ETF launch pushback adds to mixed sentiment.

2 weeks ago

Google Takes Aim at Nvidia With New Tensor Chips to Power AI Boom

Google’s new processors target massive model training and the emerging AI agent economy, offering distinct builds for both needs.

2 weeks ago

Tether Freezes $344 Million in USDT With U.S. Law Enforcement in Major Crypto En...

TLDR: Tether froze $344 million in USDT across two wallets after U.S. authorities flagged illicit activity links. Tether now coope...

2 weeks ago

Novo Nordisk (NVO) Stock Rises After Pediatric Diabetes Drug Trial Success

Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 2026 fi...